Close
American Drug Delivery & Formulation Summit

Medical Research Council Finds Antibody Capable of Fighting Flu

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

TRT Safety: What Current Research Actually Says About Long-Term Use

Testosterone replacement therapy has spent years caught between two...

Merck Signs Voluntary Licensing Deals for Oral HIV Pill

Merck has entered into seven voluntary licensing agreements with...

Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort

President Donald Trump announced plans to implement massive generic...
- Advertisement -

An antibody that can fight all types of the influenza A virus has been identified by researchers from the Medical Research Council’s National Institute for Medical Research.

Studies in fly-infected mice showed that the antibody could be used as an emergency treatment or in the development of a universal vaccine, rather than be used to create a new vaccine each winter. The antibody, named FI6, targets a protein found on the surface of the virus, called haemagglutinin. Mice infected with a lethal dose of the H1N1 virus were injected with the antibody two days after the virus was recorded and survived.

ย 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

TRT Safety: What Current Research Actually Says About Long-Term Use

Testosterone replacement therapy has spent years caught between two...

Merck Signs Voluntary Licensing Deals for Oral HIV Pill

Merck has entered into seven voluntary licensing agreements with...

Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort

President Donald Trump announced plans to implement massive generic...

What to Look for in a Supplement Manufacturer

Finding a supplement manufacturer is relatively easy. Finding one...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป